Stakeholders disagree over FDA’s regulatory approach to generative AI

Regulatory NewsRegulatory NewsAdvisory committeesArtificial intelligence/machine learning (AI/ML)Diagnostics/IVDsDigital health/SaMD/AIMedical DevicesRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)